Company Reports

GEA Group is a leading supplier of process equipment and systems, focused primarily on the food, beverage, and pharmaceutical industries, which together account for nearly three-fourths of sales. The company concentrates on mission-critical applications where hygiene, reliability, and regulatory compliance are paramount. Its two wide-moat divisions—pure flow processing and farm technologies—generate roughly two-thirds of group EBITDA, with entrenched market leadership, high service intensity, and strong pricing power.

GEA Group delivered record second-quarter EBITDA margins and accelerated organic growth, prompting a second 2026 guidance raise and a new EUR 500 million share buyback.

GEA Group is a leading supplier of process equipment and systems, focused primarily on the food, beverage, and pharmaceutical industries, which together account for nearly three-fourths of sales. The company concentrates on mission-critical applications where hygiene, reliability, and regulatory compliance are paramount. Its two wide-moat divisions—separation and flow technologies and farm technologies—generate roughly two-thirds of group EBITDA, with entrenched market leadership, high service intensity, and strong pricing power.

GEA Group delivered first-quarter organic sales growth of 5.3%, inside its 5%-7% full-year guidance range, in a quarter that management had explicitly guided would fall short of it. EBITDA margin expanded to a new first-quarter record of 16.2%. Guidance was unchanged.

GEA Group delivered a standout 2025, with an EBITDA margin of 16.5% beating upgraded guidance and organic order intake climbing 9.1% to EUR 5.9 billion, the strongest intake on record.

GEA Group is a leading supplier of process equipment and systems, focused primarily on the food, beverage, and pharmaceutical industries, which together account for nearly three-fourths of sales. The company concentrates on mission-critical applications where hygiene, reliability, and regulatory compliance are paramount. Its two wide-moat divisions—separation and flow technologies and farm technologies—generate roughly two-thirds of group EBITDA, with entrenched market leadership, high service intensity, and strong pricing power.

GEA posted strong organic order growth, with EBITDA margins exceeding guidance in its fourth-quarter 2025 trading update.

GEA reported a strong third-quarter 2025, delivering EBITDA growth of 7% and record margins driven by organic growth and operational efficiencies. All major divisions contributed to profitability improvement, led by Farm Tech.

We take a fresh look at GEA Group as we transfer coverage. GEA is a leading global supplier of equipment and systems for the food, beverage, and pharmaceutical industries, with a strong focus on hygiene-critical applications where reliability, efficiency, and regulatory compliance are paramount.

GEA Group is a leading supplier of process equipment and systems, focused primarily on the food, beverage, and pharmaceutical industries, which together account for nearly three-quarters of sales. The company concentrates on mission-critical applications where hygiene, reliability, and regulatory compliance are paramount. Its two wide moat divisions—separation & flow technologies and farm technologies—generate roughly two-thirds of group EBITDA, with entrenched market leadership, high service intensity, and strong pricing power.

GEA Group reported a solid second-half 2025, with organic order and sales growth of 5% and 1.5%, respectively. EBITDA prerestructuring rose 8% to a record 16.5% margin. Service revenue grew 4.6% organically, lifting mix to 40.1%. Management raised guidance on an improved market outlook.

GEA Group is a leading supplier of highly engineered capital equipment and solutions to the food processing and pharmaceutical manufacturing industries. GEA’s reputation for innovation and safety positions the company to win equipment orders—particularly from customers who are sensitive to reputational risk from incidents of food contamination and those who wish to differentiate their product offerings.

GEA group reported first-quarter 2025 revenue growth of 1% and lifted its EBITDA margin to a first-quarter record 15.8%. Orders grew 3% organically, taking book/bill to 1.12 times, supporting a firm backlog in a subdued macro environment.

Order intake for wide-moat GEA Group continued its upward trajectory in 2024, rising 1.5% year over year to EUR 5.5 billion with organic growth of 4.6%. Strong demand across dairy processing, food, and pharma, coupled with a robust pipeline of large orders, helped offset ongoing macroeconomic uncertainties. Service revenue remained a key driver of profitability, expanding in all five divisions and accounting for approximately 38% of total revenue—up from approximately 36% in 2023. This positive mix shift contributed to an 8% increase in adjusted EBITDA to EUR 837 million, with EBITDA margins expanding by 100 basis points to 15.4%. With resilient end markets, an expanding high-margin service business, and disciplined capital allocation, GEA remains well positioned to maintain earnings growth. The stock has performed well over the past year, pushing it into overvalued territory. It is trading 20% above our unchanged EUR 48 per-share fair value estimate.

Order intake for wide-moat GEA Group turned a corner in the third quarter of 2024, with new orders flat sequentially and rising 6.6% organically year on year, representing a pleasing outcome given still soft manufacturing sector activity, particularly in Europe. The improvement in demand was broad-based—with all divisions contributing positively to order intake during the third quarter. We expect the combination of recovering demand in late 2024 and GEA’s healthy order backlog—which stood at EUR 3.0 billion at the end of September—to support earnings growth in late 2024 and 2025. GEA screens as modestly undervalued, trading at an approximate 6% discount to our unchanged EUR 48 fair value estimate.

We lift our fair value estimate by 7% for wide-moat GEA Group to EUR 48, following the announcement of a number of key growth and cost-out initiatives at its 2024 capital markets day. GEA discussed a range of growth opportunities that are expected to support earnings growth over the 2025-30 period, including innovative equipment and solutions to address the growing demand for alternative food proteins and that deliver energy efficiency for its customers. GEA also announced a range of cost-out initiatives that have the potential to widen its profit margins in coming years.

GEA Group is a leading supplier of highly engineered capital equipment and solutions to the food processing and pharmaceutical manufacturing industries. GEA’s reputation for innovation and safety positions the company to win equipment orders—particularly from customers who are sensitive to reputational risk from incidences of food contamination and those who wish to differentiate their product offerings.

We make no change to our EUR 45 fair value estimate with wide-moat GEA Group’s second-quarter 2024 offering resilient top-line growth and pleasing profit margin expansion amid otherwise tepid demand conditions. Order intake remained soft, declining 3.5% year on year on an organic basis amid still weak industrial output, particularly in Europe. Second-quarter order intake for the separation and flow and heating and refrigeration segments were bright spots amid the otherwise weak demand environment as new orders from food, pharmaceutical, and distribution and storage customer industries rebounded. While second-quarter orders tracked broadly in line with our full-year expectations, we’ve lowered our full-year order intake forecast by 3% to EUR 5.2 billion to account for currency headwinds, which we expect will offer a greater drag on order intake than we’d previously credited. GEA shares screen as undervalued, trading at a 12% discount to our unchanged valuation.

GEA Group is a leading supplier of highly engineered capital equipment and solutions to the food processing and pharmaceutical manufacturing industries. GEA’s reputation for innovation and safety positions the company to win equipment orders—particularly from customers who are sensitive to reputational risk from incidences of food contamination and those who wish to differentiate their product offerings.

Wide-moat GEA Group delivered an impressive first-quarter result that featured resilient top-line growth—amid a weakened demand environment for food manufacturing equipment—coupled with robust profit margin progression. As we'd expected, demand for food processing equipment remains weak in early 2024, leading GEA's first-quarter order intake to fall about 10% organically. The decline in new orders was relatively broad-based, with all divisions reporting weakened order intake, aside from the food and healthcare technologies division, which benefited from a large order from a pharmaceutical customer).